Skip to main content
Equibles

BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in ZYME — Zymeworks Inc.

CIK 1520354 Paris, I0
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$46,558,370
-$1,218,925 QoQ
Shares Held
1,781,116
-6.7% QoQ
Ownership
2.51%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#7
of 202 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,299,463 across 137 Biotechnology names. ZYME ranks #17 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 897,893 $446,010,389
2 REGN
Regeneron Pharmaceuticals, Inc.
 331,560 $206,740,921
3 JAZZ
Jazz Pharmaceuticals plc
 799,297 $192,606,596
4 ARGX
Argenx SE
 121,786 $112,989,396
5 INCY
Incyte Corp
 937,763 $106,304,813
6 XENE
Xenon Pharmaceuticals Inc.
 1,290,731 $77,908,522
7 VCEL
Vericel Corp
 1,639,988 $72,963,065
8 CYTK
Cytokinetics Inc
 827,810 $70,521,132

All Filings in ZYME

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,558,370 1,781,116
2026-03-31 $47,777,295 1,908,039
2025-12-31 $47,974,522 1,822,048
2025-06-30 $25,597,682 2,039,656
2025-03-31 $26,176,738 2,197,879
2024-12-31 $31,295,239 2,137,653
2024-09-30 $24,415,911 1,945,491
2024-06-30 $16,431,848 1,930,887
2024-03-31 $20,069,151 1,907,714
2023-12-31 $18,408,751 1,771,776
2023-09-30 $9,879,310 1,558,251
2023-06-30 $18,788,543 2,174,600
2023-03-31 $20,850,506 2,306,472
2022-12-31 $18,013,602 2,291,807